None listed
Conditions
Interventions
Others : 1) Control group: Basic educational materials are provided, and standard treatment is performed in accordance with the standard treatment guidelines of the Korean Breast Cancer Society.
2) In
Sponsors
The Catholic University of Korea, St. Vincent's Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: To participate in this clinical trial, you must meet all of the following criteria. 1) Patients who were histologically diagnosed with breast cancer and underwent curative surgery (patients without residual breast cancer) 2) Patients scheduled to receive chemotherapy according to final TNM stage after curative surgery 3) Breast cancer patients between 20 and 75 years of age 4) Patients with ECOG Performance Status Scale 0 and capable of all exercises and activities 5) Those who can use a smartphone 6) Those who agree to participate in this clinical trial and who have provided written consent
Exclusion criteria
Exclusion criteria: Subjects who meet any of the following must be excluded from this clinical trial. 1) Patients who did not receive curative surgery due to metastatic or advanced breast cancer 2) Patients not scheduled for chemotherapy 3) Those whose heart function corresponds to New Your Heart Association III-IV 4) Those who have been diagnosed with a malignant tumor other than breast cancer within the past 5 years and have not completed treatment 5) Organ transplant recipients or people who need to take long-term immunosuppressants 6) Those who have difficulty in exercise or activity due to spinal disease (intervertebral disc herniation, spinal stenosis, etc.), other joint disease, or major surgery at the time of screening 7) Those planning a surgery that is expected to limit post-surgery activities during the clinical trial period 8) Pregnant or lactating women 9) Those who are planning to become pregnant during the clinical trial period or who do not agree to use appropriate contraception 10) Those who participated as subjects in other clinical trials within 90 days of screening (excluding observational studies) 11) Persons deemed unsuitable for participation in clinical trials at the discretion of the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body fat percentage, body fat mass, skeletal muscle mass, body weight | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in patient self-care behavior | — |
Countries
Korea, Republic of
Contacts
Public ContactYewon Jeon
The Catholic University of Korea, St. Vincent's Hospital
Outcome results
None listed